# Erratum to “CCL4‐mediated targeting of spleen tyrosine kinase (Syk) inhibitor using nanoparticles alleviates inflammatory bowel disease”

PMC · DOI: 10.1002/ctm2.70434 · Clinical and Translational Medicine · 2025-08-17

## Full-text entities

- **Genes:** SYK (spleen associated tyrosine kinase) [NCBI Gene 6850] {aka IMD82, p72-Syk}, CCL4 (C-C motif chemokine ligand 4) [NCBI Gene 6351] {aka ACT2, AT744.1, G-26, HC21, LAG-1, LAG1}
- **Diseases:** inflammatory bowel disease (MESH:D015212)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13007262/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13007262/full.md

---
Source: https://tomesphere.com/paper/PMC13007262